- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 105.94M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 105.86M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 63.17M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $53K |
| Capex | Q1 2026 · Mar 31, 2025 | $163K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$9.09M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $198.02M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $76.95M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $97.16M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $288.6M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $295.41M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.05M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $5.92M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.57M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $7.57M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $276.74M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $299.56M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $295.17M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $302.98M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.10 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.10 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.10 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $7.3M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $4.57M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.41M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$10.5M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$11.93M |